Ibogaine Treatment Guide: How to Use This Independent Resource

Most people arrive here in the middle of something difficult. A relapse. A tapering plan that stalled. A brother who has tried everything. A stack of browser tabs, half of them sales pages dressed up as education, and no obvious way to tell which is which.

This page is the map. It explains what this guide is, what it deliberately is not, and the shortest route from where you are standing to the information you actually need.

If you would rather just start reading, the complete ibogaine guide is the main entry point.

---

What this guide is — and what it is not

This is an independent informational resource. We do not operate a clinic. We do not administer ibogaine. We do not take referral fees for sending you somewhere, and we do not sell treatment.

That independence is the whole point. Almost every well-resourced ibogaine website on the internet belongs to a provider. Provider-published content is not necessarily dishonest, but it has an unavoidable structural bias: it exists to fill beds. When the same organisation writes both the safety page and the booking page, the safety page tends to get quieter about the things that would cost a booking.

So this guide is built on a simple rule: cover the parts that hurt. The cardiac risk. The deaths. The medications that make ibogaine dangerous. The relapse rates when aftercare is skipped. The clinics that should not be operating. If a fact would make a provider uncomfortable, that is usually a sign it belongs here.

What this guide is not:

• Not medical advice. Nothing here can substitute for a clinician who has seen your ECG and your medication list.
• Not a booking service. We do not arrange treatment, hold deposits, or broker introductions.
• Not an endorsement engine. Our clinic directory documents what providers claim and what standards they should meet. Listing is not endorsement.
• Not a promise that ibogaine works for you. The evidence base is genuinely promising and genuinely thin. We try hard not to blur that line.

You can read more about our editorial approach and funding on the about this guide page.

---

Start here: three paths through the guide

People arrive with very different questions. Pick the path that matches yours.

Path 1 — You are considering ibogaine for yourself

Read in this order:

1. What is ibogaine — the substance, its origin, and what it plausibly does
2. Ibogaine safety protocols — read this before anything else, without exception
3. The ibogaine treatment process — screening, dosing, monitoring, discharge
4. What to expect during treatment — the honest experiential account
5. Ibogaine aftercare and integration — the stage that most determines whether it holds

Then, before you contact anyone, run the ibogaine pre-screening tool and the medication interaction checker.

Path 2 — You are researching for a family member

Your questions are different. Start with:

1. Ibogaine addiction treatment — what interruption actually means, and what it does not
2. Ibogaine safety protocols — so you know what to demand of any provider
3. Choosing an ibogaine clinic — the red flags, in order of severity
4. Ibogaine treatment cost — including the costs that get quoted late

The hardest thing to accept from this position: you cannot screen someone else's heart. If a provider is willing to treat your family member without a recent ECG, a full medication review, and continuous cardiac monitoring, that is disqualifying. Not a yellow flag. Disqualifying.

Path 3 — You are a clinician or researcher

Go straight to ibogaine research and clinical studies, the ibogaine case studies collection, and the live ibogaine clinical trials tracker, which pulls current registry data rather than a hand-maintained list.

---

The safety material you should read before anything else

If you read exactly one page on this site, make it ibogaine safety.

Ibogaine is not a low-risk substance with an unfortunate legal status. It carries a real, documented, mechanism-understood cardiac risk. It blocks hERG potassium channels, which prolongs the QT interval, which can trigger torsades de pointes — a fatal arrhythmia. Deaths have occurred. Most involved undiagnosed cardiac conditions, dangerous drug interactions, unsupervised settings, or all three.

The non-negotiables that page covers in full:

• Pre-treatment ECG and cardiac workup. Not optional. Not waivable.
• Full medication reconciliation. SSRIs, SNRIs, MAOIs, certain antibiotics, antipsychotics, and many other QT-prolonging drugs create compounding risk. Our SSRI tapering guide covers why abrupt discontinuation is its own hazard.
• Continuous cardiac monitoring throughout. A nurse checking in periodically is not monitoring.
• Liver function and electrolyte screening. Magnesium and potassium correction before dosing.
• Opioid taper planning. Short-acting versus long-acting matters enormously, and methadone in particular complicates timing.
• Emergency capability on site. Crash cart, defibrillator, and someone who knows how to use both.

If any of that is missing, the correct response is to walk away.

---

Understanding the treatment itself

Ibogaine is not one protocol. The guide separates the main approaches because they carry different risk profiles and different evidence:

• Flood dosing — the full-dose, single-session approach most associated with addiction interruption, covered inside the ibogaine treatment process
• Ibogaine microdosing — low-dose protocols, where the evidence is considerably thinner than the enthusiasm

For the experience itself — the acute phase, the waking-dream state, the long grey day afterwards — what to expect is written from accounts rather than marketing copy. It is not uniformly pleasant, and we do not pretend otherwise.

---

Conditions and comparisons

Ibogaine is researched across a range of indications, with wildly varying levels of evidence behind each. The guide keeps them separate rather than blurring them into one optimistic story:

Substance use: addiction treatment as the hub, with dedicated coverage of fentanyl — where the pharmacology of long-acting synthetic opioids genuinely changes the calculus.

Mental health: ibogaine and mental health covers depression, anxiety, and trauma indications, where evidence is earlier-stage than the addiction literature.

Neurological: ibogaine and Parkinson's disease is a genuinely interesting research direction and, at present, a preliminary one.

Comparison pages exist because "is ibogaine better than X" is the actual question most people are asking. They are written to be usable by someone currently on the comparator — not to talk anyone off a medication that is working.

---

Cost, legality, and choosing a provider

Three practical questions, three pages:

Ibogaine treatment cost — what drives price, what is typically bundled, and which costs surface after the deposit. The cost calculator produces a range from your own parameters rather than a single misleading figure.

Ibogaine legal status — jurisdiction by jurisdiction. The short version: Schedule I in the United States, unscheduled or differently regulated in a number of other countries, which is why treatment tourism exists at all.

Choosing an ibogaine clinic — the most consequential page on this site. Region-specific detail lives in the Mexico ibogaine clinic guide, since Mexico is where a large share of treatment occurs.

---

Tools that do the work for you

Reading is slow. These are built to give you a usable answer in a few minutes:

| Tool | What it answers | |---|---| | Pre-screening tool | Are there obvious disqualifiers in my history? | | Medication interaction checker | Does anything I take create QT or serotonergic risk? | | Cost calculator | What range should I actually budget for? | | Clinical trials tracker | What research is genuinely open right now? | | Recovery visualizer | What does the timeline after treatment look like? |

A caution on the pre-screening and medication tools: they catch the obvious problems. They are a filter, not a clearance. Passing them does not mean you are a candidate — only a clinician with your ECG can say that.

---

How this guide is maintained

Ibogaine information rots quickly. Clinics open and close. Legal status shifts at state level. Trials change status. A guide written in 2023 and left alone is actively misleading by 2026.

Our maintenance commitments:

• Registry data is pulled live rather than transcribed, so the trials tracker cannot silently go stale.
• Legal status is reviewed on a rolling basis, because state-level activity in the US has been moving fast.
• Clinic listings are re-checked, and entries are removed when a provider cannot be verified as operating.
• Corrections are made rather than quietly deleted. If we get something wrong and you can show us, we would genuinely like to know — contact us.

Ongoing developments are covered in ibogaine news.

---

Frequently asked questions

Is this site run by a treatment provider? No. This is an independent informational resource. We do not operate a clinic, administer treatment, arrange bookings, or accept referral fees.

Can you tell me which clinic to use? No, and be sceptical of any site that will. We publish the criteria and the red flags in choosing an ibogaine clinic so you can evaluate providers yourself.

Can you tell me whether I am a candidate? No. That requires an ECG, a full medication review, and a qualified clinician. The pre-screening tool will flag obvious disqualifiers, but a clear result is not medical clearance.

Where should I start if I only have ten minutes? What is ibogaine, then ibogaine safety. In that order.

Is ibogaine legal where I live? Check ibogaine legal status. In the United States it is a Schedule I controlled substance.

Do you have answers to more specific questions? The ibogaine FAQ covers the recurring ones in more depth.

---

The bottom line

This guide exists because the honest version of the ibogaine story is harder to find than it should be, and because the people searching for it are usually out of easy options and short on time.

The honest version is roughly this: there is real, serious scientific interest here, an early evidence base that justifies that interest without yet confirming it, a genuine and non-trivial risk of death when screening is skipped, and a provider landscape whose quality ranges from excellent to indefensible.

Hold all four of those at once and you are already reading this subject better than most. Start with what is ibogaine and work outward.

---

Medical disclaimer: Ibogaine Treatment Guide is an independent informational resource. We are not a treatment provider and do not administer, arrange, or sell treatment. This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Ibogaine is a Schedule I controlled substance in the United States and carries serious cardiac risks, including QT prolongation and potentially fatal arrhythmia. It should never be used outside a medically supervised setting with full cardiac screening and continuous monitoring. Never start, stop, or change any medication based on information found here. Always consult a qualified healthcare professional.

If you are in crisis: call or text 988 (Suicide & Crisis Lifeline, US), or dial your local emergency number. For a medical emergency, call 911. For free, confidential treatment referrals in the US, the SAMHSA National Helpline is available 24/7 at 1-800-662-4357.